Analysts think TELO stock price could increase by 147%
Jan 27, 2025, 12:25 PM
-17.37%
What does TELO do
Telomir Pharmaceuticals, a preclinical-stage company based in Tampa, Florida, focuses on developing TELOMIR-1 to lengthen DNA's telomere caps for age reversal. It went public on February 9, 2024.
3 analysts think TELO stock price will increase by 147.37%. The current median analyst target is $12.39 compared to a current stock price of $5.01. The lowest analysts target is $12.27 and the highest analyst target is $12.76.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
